Drug Patent Expirations in July 2011
Drug Patent Expirations in July 2011
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| ALAMAST | Santen | pemirolast potassium | 5,034,230*PED | Jul 2, 2011 |
| ANZEMET | Sanofi Aventis Us | dolasetron mesylate | 4,906,755 | Jul 2, 2011 |
| ISTODAX | Celgene | romidepsin | 4,977,138 | Jul 6, 2011 |
| VISIPAQUE 320 | Ge Healthcare | iodixanol | RE36418 | Jul 12, 2011 |
| VISIPAQUE 270 | Ge Healthcare | iodixanol | RE36418 | Jul 12, 2011 |
| MESNEX | Baxter Hlthcare | mesna | 5,262,169 | Jul 16, 2011 |
| MESNEX | Baxter Hlthcare | mesna | 5,252,341 | Jul 16, 2011 |
| UROXATRAL | Sanofi Aventis Us | alfuzosin hydrochloride | 4,661,491*PED | Jul 18, 2011 |
| EQUETRO | Validus Pharms Inc | carbamazepine | 5,326,570 | Jul 23, 2011 |
| CARBATROL | Shire | carbamazepine | 5,326,570 | Jul 23, 2011 |
| RAPAMUNE | Wyeth Pharms Inc | sirolimus | 5,145,684*PED | Jul 25, 2011 |
| DENTIPATCH | Noven | lidocaine | 5,332,576 | Jul 26, 2011 |
| MULTAQ | Sanofi Aventis Us | dronedarone hydrochloride | 5,223,510 | Jul 26, 2011 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.
Courtesy of DrugPatentWatch.com



















Recent Comments